ARCHIVES

The Raghavan Experiment: With $500 Million to Draw On, An Iconoclast Invents Rational Care for a Gigantic System

This article is from The Cancer Letter archive.

Vol. 39 No. 01 | January 4, 2013

Download PDF Visit The Full Archive

Related Articles

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

Mason Asks For Better Technology Transfer In Cancer Prevention

October 30, 1992

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Litton Sells Clinical Labs, Planning to Join Recompetition For FCRF Contracts

July 12, 1985

NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile.

November 28, 2003